Emergent BioSolutions Acquires Adapt Pharma in $735 Million DealAllbiopro2018-08-30T10:19:16+09:008월 30th, 2018|
Sartorius Sets Up Life Science Factory For Startup EntrepreneursAllbiopro2018-08-30T10:18:20+09:008월 30th, 2018|
In FDA petition, Pfizer blasts ‘misleading’ biosims messages from J&J, Amgen and RocheAllbiopro2018-08-30T10:17:51+09:008월 30th, 2018|
Eyeing $1B annual sales, Emergent BioSolutions to buy Narcan maker Adapt for $735MAllbiopro2018-08-30T10:17:22+09:008월 30th, 2018|
Gilead steals new commercial chief from Amgen to tackle big sales challengesAllbiopro2018-08-30T10:16:50+09:008월 30th, 2018|
With PBMs gaining power, pharma and ad agencies zero in on payer marketingAllbiopro2018-08-30T10:16:18+09:008월 30th, 2018|
Merck’s latest digital diabetes coach aims to fill education and support gapsAllbiopro2018-08-30T10:15:49+09:008월 30th, 2018|
Ascend scolded—again—for estrogen drug promos in OPDP’s 4th warning this yearAllbiopro2018-08-30T10:15:20+09:008월 30th, 2018|
Targeting a market Big Pharma’s fleeing, Tetraphase wins FDA nod for antibiotic XeravaAllbiopro2018-08-30T10:14:50+09:008월 30th, 2018|
Reality check for Hong Kong biotech IPOs as Ascletis slipsAllbiopro2018-08-30T10:14:21+09:008월 30th, 2018|
Targeting Alzheimer’s with a soluble toll-like receptorAllbiopro2018-08-30T10:13:53+09:008월 30th, 2018|
Xenon’s epilepsy drug clears phase 1b, setting stage for trial in patientsAllbiopro2018-08-30T10:13:25+09:008월 30th, 2018|
Biotech boom powers analysts to $4M-a-year salaries: WSJAllbiopro2018-08-30T10:12:56+09:008월 30th, 2018|
Women’s health firm KaNDy raises $32M for menopause studyAllbiopro2018-08-30T10:12:27+09:008월 30th, 2018|
Urovant adds gene therapy to overactive bladder pipelineAllbiopro2018-08-30T10:11:58+09:008월 30th, 2018|
Novartis constructing $92m CAR-T plant as Kymriah arrives in EUAllbiopro2018-08-30T10:11:29+09:008월 30th, 2018|
